In this study, we performed immunohistochemical analyses to examine HMGB1 expression in surgically resected specimens of rectal cancer after preoperative CRT and investigated its association with clinicopathological features, in an attempt to elucidate the possible association between HMGB1 expression and resistance to CRT. This evidence concerns the gene HMGB1 and rectal cancer.